Stay updated on Atezolizumab in Advanced NSCLC Clinical Trial

Sign up to get notified when there's something new on the Atezolizumab in Advanced NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Atezolizumab in Advanced NSCLC Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    Revision: v3.5.2 was added and Revision: v3.5.0 was removed.
    Difference
    0.1%
    Check dated 2026-04-16T10:33:58.000Z thumbnail image
  2. Check
    7 days ago
    No Change Detected
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    No Change Detected
  5. Check
    29 days ago
    Change Detected
    Summary
    Page revision updated from v3.4.3 to v3.5.0.
    Difference
    0.1%
    Check dated 2026-03-18T15:40:54.000Z thumbnail image
  6. Check
    36 days ago
    Change Detected
    Summary
    Revision tag updated from v3.4.2 to v3.4.3 on the page.
    Difference
    0.1%
    Check dated 2026-03-11T17:58:41.000Z thumbnail image
  7. Check
    64 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2; removed the government funding lapse notice and Revision: v3.4.1.
    Difference
    0.4%
    Check dated 2026-02-11T10:31:23.000Z thumbnail image
  8. Check
    71 days ago
    Change Detected
    Summary
    A government funding lapse notice was added to the page. The site revision was updated to v3.4.1, replacing the previous v3.4.0.
    Difference
    0.4%
    Check dated 2026-02-04T06:27:07.000Z thumbnail image
  9. Check
    78 days ago
    Change Detected
    Summary
    Glossary is now displayed; QC-related labels were updated to 'Last Update Submitted that Met QC Criteria' and 'Revision: v3.4.0'. Capitalization for 'No FEAR Act Data' has been standardized.
    Difference
    0.2%
    Check dated 2026-01-28T05:10:05.000Z thumbnail image

Stay in the know with updates to Atezolizumab in Advanced NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Atezolizumab in Advanced NSCLC Clinical Trial page.